MDxHealth (MDxHealth) EV-to-Revenue : 1.40 (As of May. 15, 2024)

View and export this data going back to 2008. Start your Free Trial

What is MDxHealth EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, MDxHealth's enterprise value is $105.20 Mil. MDxHealth's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was $75.33 Mil. Therefore, MDxHealth's EV-to-Revenue for today is 1.40.

The historical rank and industry rank for MDxHealth's EV-to-Revenue or its related term are showing as below:

MDXH' s EV-to-Revenue Range Over the Past 10 Years
Min: -0.19 Med: 2.15 Max: 34.21
Current: 1.4

During the past 13 years, the highest EV-to-Revenue of MDxHealth was 34.21. The lowest was -0.19. And the median was 2.15.

MDXH's EV-to-Revenue is ranked better than
77.03% of 222 companies
in the Medical Diagnostics & Research industry
Industry Median: 3.195 vs MDXH: 1.40

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-15), MDxHealth's stock price is $2.815. MDxHealth's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $2.66. Therefore, MDxHealth's PS Ratio for today is 1.06.

MDxHealth EV-to-Revenue Historical Data

The historical data trend for MDxHealth's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MDxHealth EV-to-Revenue Chart

MDxHealth Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

5.65

4.96

5.36

3.42

1.80

MDxHealth Quarterly Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial															-0.19	1.68	1.29	1.80	1.29

Competitive Comparison of MDxHealth's EV-to-Revenue

For the Diagnostics & Research subindustry, MDxHealth's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MDxHealth's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, MDxHealth's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where MDxHealth's EV-to-Revenue falls into.

MDxHealth EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

MDxHealth's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	105.195	/	75.327
	=	1.40

MDxHealth's current Enterprise Value is $105.20 Mil.
MDxHealth's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $75.33 Mil.

MDxHealth (NAS:MDXH) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

MDxHealth's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	2.815	/	2.66
	=	1.06

MDxHealth's share price for today is $2.815.
MDxHealth's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.66.

MDxHealth EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of MDxHealth's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

MDxHealth (MDxHealth) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » MDxHealth SA (NAS:MDXH) » Definitions » EV-to-Revenue

Comparable Companies

BIOQ PSNL VNRX PRE ENZ PRPH ACRS BNR DRIO AWH TMO DHR IQV XSWX:LONN IDXX A MTD ICLR ILMN WAT

Traded in Other Exchanges

N/A

Address

Rue d’Abhooz, 31, Cap Business Center, Herstal, Liege, BEL, 4040

Website

https://www.mdxhealth.com

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA), and Europe.